Innovation will spearhead Novartis's growth, Lek CEO says
Ljubljana, 17 February - Innovation is the main engine of Novartis's growth and Slovenia will continue to play a crucial role in innovative technologies, chairman of Novartis-owned pharma company Lek, Zvone Bogdanovski, told the STA in an interview. He highlighted Lek's centre for the production of active substances for innovative medicines in Mengeš.
Ljubljana
Interview with the CEO of pharma company Lek, Zvone Bogdanovski.
Photo: Bor Slana/STA
Ljubljana
Interview with the CEO of pharma company Lek, Zvone Bogdanovski.
Photo: Bor Slana/STA
Ljubljana
Interview with the CEO of pharma company Lek, Zvone Bogdanovski.
Photo: Bor Slana/STA
Ljubljana
Interview with the CEO of pharma company Lek, Zvone Bogdanovski.
Photo: Bor Slana/STA
Ljubljana
Interview with the CEO of pharma company Lek, Zvone Bogdanovski.
Photo: Bor Slana/STA
Ljubljana
Interview with the CEO of pharma company Lek, Zvone Bogdanovski.
Photo: Bor Slana/STA
Ljubljana
Interview with the CEO of pharma company Lek, Zvone Bogdanovski.
Photo: Bor Slana/STA
Ljubljana
Interview with the CEO of pharma company Lek, Zvone Bogdanovski.
Photo: Bor Slana/STA
Ljubljana
Interview with the CEO of pharma company Lek, Zvone Bogdanovski.
Photo: Bor Slana/STA
The rest of this news item is available to subscribers.
The news item consists of 3.400 characters (without spaces) or 621 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.